Related Experiment Video

Updated: Aug 17, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Novel therapeutics in colorectal cancer

Robert R McWilliams1, Charles Erlichman

  • 1Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA. mcwilliams.robert@mayo.edu

Diseases of the Colon and Rectum
|May 21, 2005
PubMed

Insights

Novel therapeutics targeting intracellular pathways show promise for advanced colorectal cancer treatment. Research focuses on molecular targets for tailored prevention and therapy strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Translational Research

Background:

  • Colorectal cancer serves as a key model for therapeutic strategy evaluation.
  • Understanding cancer development, spread, and growth informs tailored treatment approaches.
  • Recent advances focus on intracellular pathways driving tumor formation, invasion, and metastasis.

Purpose of the Study:

  • To review novel therapeutics for advanced colorectal cancer.
  • To examine the scientific rationale and clinical trial results of targeted therapies.
  • To suggest clinical applications and future research directions.

Main Methods:

  • Review of scientific literature on colorectal cancer molecular pathways.
  • Analysis of clinical trial data for novel targeted therapeutics.
  • Identification of specific molecular targets for intervention.

Main Results:

  • Targeting intracellular pathways like growth factor receptors, proliferation signaling, cell cycling, apoptosis, angiogenesis, and matrix metalloproteinases is feasible.
  • Clinical trials are evaluating the efficacy of these novel therapeutics.
  • Progress in advanced disease therapy may inform early or premalignant disease treatment.

Conclusions:

  • Novel therapeutics targeting specific molecular processes offer potential for advanced colorectal cancer treatment.
  • Tailored therapeutic strategies based on mechanistic understanding are crucial.
  • Continued research is needed to optimize clinical settings and explore future directions.

More Related Videos

Subcutaneous Injection of Human Colorectal Cancer Cells in Athymic Nude Mice to Evaluate Antitumor Efficacy06:35

Subcutaneous Injection of Human Colorectal Cancer Cells in Athymic Nude Mice to Evaluate Antitumor Efficacy

Published on: July 8, 2025

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...